Jason B. Fleming - Concepedia

Author

Jason B. Fleming

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Asif Rashid, Christina L Roland, Fleming, Jason, J B Fleming, J Wolff, J. B. Fleming, J. Fleming, J.B. Fleming, JASON FLEMING, James L Abbruzzese

903

Publications

31.3K

Citations

H-Index

159

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Moffitt Cancer Center The University of Texas Southwestern Medical Center Society of Surgical Oncology University of Florida

About

Jason B. Fleming is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	57	115	10.6K
2	Health Sciences	15	15	1.2K
3	Engineering	6	6	234
4	Natural Sciences	2	2	223
5	Education	1	1	14

Jason B. Fleming

240

Publications

24.1K

Citations

H-Index

Page 1

	Year	Citations
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway Jaekyoung Son, Costas A. Lyssiotis, Haoqiang Ying, Nature	2013	1.9K
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine Leore T. Geller, Michal Barzily-Rokni, Tal Danino, Science	2017	1.7K
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function Andrea Viale, Piergiorgio Pettazzoni, Costas A. Lyssiotis, Nature Pancreatic CancerMitochondrial FunctionMedicineOncologyCell Biology	2014	1.2K
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans, Journal of the American College of Surgeons	2008	813
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer Surendra K. Shukla, Vinee Purohit, Kamiya Mehla, Cancer Cell Tumor BiologyImpart Gemcitabine ResistancePancreatic CancerOncogenic AgentMedicine	2017	531
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale, Cancer	2012	519
KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma Jianhua Ling, Ya’an Kang, Ruiying Zhao, Cancer Cell Tumor BiologySignal TransductionSignaling PathwayPancreatic CancerMedicine	2012	515
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma Matthew H. G. Katz, Huamin Wang, Jason B. Fleming, Annals of Surgical Oncology	2009	478
Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer Ryan P. Merkow, Karl Y. Bilimoria, James S. Tomlinson, Annals of Surgery	2013	426
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice Michael P. Kim, Douglas B. Evans, Huamin Wang, Nature Protocols Tumor BiologyXenotransplantationPancreatic CancerOncogenic AgentMedicine	2009	381

Page 1